Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
05/2005
05/03/2005US6887865 N-heterocyclic derivatives as NOS inhibitors
05/03/2005US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors
05/03/2005CA2133337C Compounds useful for treating allergic or inflammatory diseases
05/03/2005CA2114114C Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors
04/2005
04/28/2005WO2005037843A1 Compositions useful as inhibitors of protein kinases
04/28/2005WO2005037825A2 Protein kinase inhibitors
04/28/2005WO2005037802A1 5-arylpyrimidine derivative
04/28/2005WO2005037800A1 Sulfoximine-substituted pyrimidines for use as cdk and/or vegf inhibitors, the production thereof and their use as drugs
04/28/2005WO2005037799A1 Compounds, compositions, and methods
04/28/2005WO2005037793A1 Cyclopentene compounds
04/28/2005WO2005037763A1 Phenoxyether derivatives as ppar modulators
04/28/2005WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation
04/28/2005US20050090668 Via condensation of dihydroxyfumarate derivatives with amidines; chemical intermediates
04/28/2005US20050090559 Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents
04/28/2005US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria
04/28/2005US20050090515 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors
04/28/2005US20050090514 Cool-genic compounds as anticarcinogenic agents promoting apoptosis and inhibit angiogenesis; antiproliferative agents
04/28/2005US20050090504 Crohn's disease, ulcerative colitis, asthma, hypersensitivity pneumonitis, eosinophilic pneumonias, rhinitis, psoriasis, dermatitis and eczema
04/28/2005US20050090503 5-HT receptor ligands and uses thereof
04/28/2005US20050090500 Oral administration of a crystalline form of erlotinib hydrochloride to treat cancer expressing epidermal growth factor receptor (EGFR), including non-small cell lung cancer, head and neck cancer, or ovarian cancer
04/28/2005US20050090493 Useful as anti-cancer agents; exhibit apoptotic effect in a warm-blooded animal such as man; for example, 2-{4-[3-(N,N-Dimethyl)amino-2-hydroxy-propoxy]anilino}-4-(2,4-difluoro-(N-cyanomethyl)anilino)pyrimidine
04/28/2005US20050090490 3-Substituted-4-pyrimidone derivatives
04/28/2005US20050090486 Trisubstituted pyrimidines
04/28/2005CA2542492A1 Sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents
04/28/2005CA2542113A1 Compositions useful as inhibitors of protein kinases
04/28/2005CA2542076A1 Substituted tricyclic compounds as protein kinase inhibitors
04/28/2005CA2541751A1 Phenoxyether derivatives as ppar modulators
04/27/2005EP1525186A1 Inhibitors of hcv ns5b polymerase
04/27/2005EP1525185A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease
04/27/2005EP1525183A1 Inhibitors of hcv ns5b polymerase
04/27/2005EP1261327B1 Adenosine receptor modulators
04/27/2005EP1040098B1 Integrin receptor antagonists
04/27/2005EP1025097B1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d 4? receptor subtype ligands
04/27/2005EP1011651B1 Method of treating diabetes and related disease states
04/27/2005EP0984945B1 Substituted iminoalkoxy-phenyluracils, the production and use thereof as herbicides
04/27/2005CN1610669A Heteroaryl-substituted aminocyclohexane derivatives
04/27/2005CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
04/27/2005CN1198839C Novel dipeptide amidines as thrombin inhibitors
04/26/2005US6884903 Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation
04/26/2005US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent
04/26/2005US6884803 Phenylalkynes
04/26/2005US6884477 Electroluminescence device using liquid crystal compound
04/26/2005CA2213124C Benzoyl derivatives
04/21/2005WO2005035526A1 Bicyclic compounds and their therapeutic use
04/21/2005WO2005035518A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
04/21/2005WO2005035508A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides
04/21/2005WO2005035507A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders
04/21/2005WO2005035500A2 Therapeutic agents useful for treating pain
04/21/2005WO2005035494A1 Pyridylamino compounds and methods of use thereof
04/21/2005WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element
04/21/2005WO2005034939A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
04/21/2005WO2004089286A3 Novel compounds and compositions as protein kinase inhibitors
04/21/2005WO2004062601A3 Antibacterial agents
04/21/2005US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
04/21/2005US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents
04/21/2005US20050085637 Pyrimidine compounds
04/21/2005US20050085523 Imidazolyl and pyrazolyl ethyne compounds
04/21/2005US20050085512 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor
04/21/2005US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders
04/21/2005US20050085497 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents
04/21/2005US20050085493 Quinazolinone derivatives and their use as cb agonists
04/21/2005US20050085459 Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
04/21/2005US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer
04/21/2005CA2542031A1 Pyrimidine derivatives for treatment of hyperproliferative disorders
04/21/2005CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element
04/21/2005CA2539878A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
04/21/2005CA2539587A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
04/20/2005EP1523533A1 Luminescent compositions
04/20/2005EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments
04/20/2005EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors
04/20/2005EP1200414B1 Process for the preparation of substituted pyrimidines
04/20/2005EP1029851B1 Piperazine compounds and medicinal use thereof
04/20/2005CN1608050A Piperazine derivative
04/20/2005CN1197871C 5'-deoxy-cytidine derivatives
04/20/2005CN1197860C FAB I inhibitors
04/20/2005CN1197458C Herbicidal synergic composition and method for controlling weed
04/19/2005US6881740 Pharmaceutical agents
04/19/2005US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/14/2005WO2005033288A2 Hedgehog pathway antagonists
04/14/2005WO2005033096A1 Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof
04/14/2005WO2005033086A1 Compounds and compositions as protein kinase inhibitors
04/14/2005WO2005033085A1 Pyrimidines derivatives as adenosine receptors ligands
04/14/2005WO2005033084A1 Substituted pyrimidines as ligands of adenosine receptors
04/14/2005WO2005012241A3 p-38 KINASE INHIBITORS
04/14/2005WO2004092121A3 Methods for preparing 2,3,5,6-substituted 3h-pyrimidin-4-ones
04/14/2005WO2004092120A3 Pyrimidinone compounds as calcilytics
04/14/2005US20050080262 Process for producing quinazolin-4-one derivative
04/14/2005US20050080138 Mediators of hedgehog signaling pathways, compositions and uses related thereto
04/14/2005US20050080134 Preparing anticholesterol agent by salt formation, purification; free of impurities on an industrial scale; lower LDL-cholesterol and triglycerides
04/14/2005US20050080119 Diaminopropionic acid derivatives
04/14/2005US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
04/14/2005US20050080100 Pyridylamino compounds and methods of use thereof
04/14/2005US20050080096 Condensed heterocyclic compounds
04/14/2005US20050080090 Such as 7-(Imidazolo[4,5-b]pyridin-1-yl)-1-(1-methylpyrrolidin-3-yl)naphthalene; for treating depression, anxiety, eating disorders, drug abuse, cluster headache, migraine, pain, and other disorders arising from deficient serotonergic neurotransmission
04/14/2005US20050080088 Novel compounds
04/14/2005US20050079979 Substituted benzoylisoxazoles and the use thereof as herbicides
04/14/2005CA2540828A1 Heterocyclic amides and sulfonamides
04/14/2005CA2539339A1 Compounds and compositions as protein kinase inhibitors
04/13/2005EP1521747A2 Receptor-type kinase modulators and methods of use
04/13/2005EP1521746A1 Quinazolinone modulators of nuclear receptors